Riskpilot← Back to searchSign inGet full accessShieldheart Medtech AB
ABActiveOrg 5566561832Agneslundsvägen 27Economic activity was not specified by tax authority · NACE 0000Est. 20040 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 0
-100% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | — |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 108K | +1% |
| Equity | SEK 108K | +1% |
| Employees | 0 | — |
Legal name
Shieldheart Medtech AB
Org number
5566561832
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
17 februari 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av suppleanten
Company purpose
Bolaget skall bedriva utveckling, produktion och kommersialisering av medicintekniska produkter samt idka därmed förenlig verksamhet.
Address
Agneslundsvägen 27
Email
info@maglechemoswed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −58 | −283 | 1 551 | −2 136 | −19 | — | — | — | — | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 |
| EBIT | −58 | −283 | 1 551 | −2 136 | −19 | 0 | 0 | 0 | 0 | −2 |
| Net financials | −42 | −149 | 196 | — | — | — | — | — | 0 | −1 |
| Profit before tax | −100 | 18 | 600 | −791 | 786 | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −3 | −0 | −0 | −0 | −0 | −0 | — | −0 |
| Net profit | −100 | 18 | 597 | −791 | 786 | 0 | 0 | 0 | 0 | 0 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 966 | 3 282 | 3 069 | 1 047 | 1 809 | 107 | 107 | 107 | 107 | 108 |
| Equity | 1 197 | 1 215 | 1 812 | 1 021 | 1 807 | 107 | 107 | 107 | 107 | 108 |
| Long-term debt | 1 664 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 |
| Short-term debt | 105 | 2 067 | 1 257 | 26 | 1 | 0 | 0 | 0 | — | 0 |
| Total debt | 1 769 | 2 067 | 1 257 | 26 | 1 | — | — | — | — | — |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20152024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20152024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20152024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AT Auditor Substitute | Auditor Substitute | 2020 | — | — |
TH Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2026 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Magle Chemoswed Holding AB | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Magle Chemoswed Holding AB
Shieldheart Medtech AB Board members of Shieldheart Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Thulin | Auditor Substitute | 0 companies |
| Tomas Hilmarsson | Chief Auditor | 0 companies |
| Carl Gunnar Fredrik Ouchterlony | Board of Directors | 0 companies |
| Stig Løkke Pedersen | Deputy Board Member | 0 companies |
| Anna Hedvig Maria Lidgard Ström | Deputy Board Member | 0 companies |
| Petra Dorothea Jönsson Sjölin | Board of Directors | 0 companies |
| Aaron Michael Wong | Board of Directors | 0 companies |
| Justin Patrick Pierce | Deputy Board Member | 0 companies |
| Anna Boel Lidgard | Deputy Board Member | 0 companies |
| Hans Henrik Gunnar Lidgard | Chairman | 0 companies |